bioAffinity Technologies (BIAF) Research & Development (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Research & Development of $349707.0 for Q1 2026, down 4.81% YoY from $367386.0 in Q1 2025, and down 6.5% sequentially from $374012.0 in Q4 2025.
bioAffinity Technologies (BIAF) Research & Development (2021 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Research & Development across 6 years of filings, most recently posting $349707.0 for Q1 2026.
- In Q1 2026, Research & Development fell 4.81% year-over-year to $349707.0; the TTM figure through Mar 2026 stood at $1.4 million (down 4.83% YoY), while the FY2025 annual figure was $1.4 million, down 5.33% from the prior year.
- Research & Development declined to $349707.0 in Q1 2026, from $374012.0 in the prior quarter.
- Over the last five years, Research & Development for BIAF reached as high as $450612.0 in Q4 2022 and fell as low as $248419.0 in Q2 2022.
- The 5-year median for Research & Development is $349707.0 (2026), against an average of $350638.4.
- Annual changes were most pronounced in 2022 — Research & Development jumped 247.15% — and 2025, when it retreated 22.63%.
- A 5-year view of Research & Development shows it stood at $450612.0 in 2022, then declined by 3.95% to $432818.0 in 2023, then fell by 9.74% to $390658.0 in 2024, then declined by 4.26% to $374012.0 in 2025, then decreased by 6.5% to $349707.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $349707.0, $374012.0, and $330589.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 96.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 336.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 387.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 65.79 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 210.70 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 126.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 240.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 51.28 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | 349,707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 349,707.00 |
| Dec 31, 2025 | 374,012.00 |
| Sep 30, 2025 | 330,589.00 |
| Jun 30, 2025 | 311,372.00 |
| Mar 31, 2025 | 367,386.00 |
| Dec 31, 2024 | 390,658.00 |
| Sep 30, 2024 | 274,497.00 |
| Jun 30, 2024 | 402,433.00 |
| Mar 31, 2024 | 393,639.00 |
| Dec 31, 2023 | 432,818.00 |
| Sep 30, 2023 | 330,376.00 |
| Jun 30, 2023 | 335,125.00 |
| Mar 31, 2023 | 369,617.00 |
| Dec 31, 2022 | 450,612.00 |
| Sep 30, 2022 | 319,744.00 |
| Jun 30, 2022 | 248,419.00 |
| Mar 31, 2022 | 279,848.00 |
| Dec 31, 2021 | 129,802.00 |
| Sep 30, 2021 | 330,772.00 |